\nAc\u0163iunile Novo Nordisk au sc\u0103zut cu 15% luni, cel mai recent medicament pentru sl\u0103bit al companiei daneze dezam\u0103gind \u00eentr-un studiu clinic, noteaz\u0103 FT.<\/p>\n
\nInvestitorii au v\u00e2ndut ac\u0163iunile Novo Nordisk, listate la Copenhaga, dup\u0103 ce pierderea medie \u00een greutate ob\u0163inut\u0103 cu CagriSema, cea mai nou\u0103 injec\u0163ie s\u0103pt\u0103m\u00e2nal\u0103 a companiei, a fost sub nivelul ob\u0163inut de tirzepatid\u0103, substan\u0163a activ\u0103 din tratamentele dezvoltate de rivalul american Eli Lilly.<\/p>\n
\n\u00centr-un semn al importan\u0163ei produc\u0103torului de medicamente pentru pia\u0163a bursier\u0103 danez\u0103, indicele OMX Copenhagen 25 a sc\u0103zut cu aproape 6% p\u00e2n\u0103 spre finalul dup\u0103-amiezii.<\/p>\n
\nCagriSema a ob\u0163inut o pierdere medie \u00een greutate de 23% \u00eentr-un studiu de 84 de s\u0103pt\u0103m\u00e2ni, a anun\u0163at Novo. Prin compara\u0163ie, tirzepatida a atins 25,5%. Ac\u0163iunile Eli Lilly au crescut cu 3% \u00een tranzac\u0163iile de diminea\u0163\u0103 de pe Wall Street.<\/p>\n
\nNoul medicament al Novo con\u0163ine o molecul\u0103 nou\u0103, cagrilintid\u0103, precum \u015fi semaglutid\u0103, substan\u0163a activ\u0103 din Ozempic \u015fi Wegovy, medicamentele blockbuster care au f\u0103cut ca Novo s\u0103 devin\u0103 pentru scurt timp, \u00een 2024, cea mai valoroas\u0103 companie din Europa dup\u0103 capitalizarea bursier\u0103.<\/p>\n
\nAc\u0163iunile Novo au sc\u0103zut cu p\u00e2n\u0103 la 17% \u015fi erau \u00een minus cu 15% spre finalul \u015fedin\u0163ei.<\/p>\n
\nRezultatele pentru CagriSema \u00eencheie o perioad\u0103 dificil\u0103 de 18 luni pentru Novo. Pionierul medicamentelor pentru obezitate a r\u0103mas \u00een urma Eli Lilly, s-a confruntat cu o concuren\u0163\u0103 \u00een cre\u015ftere \u00een SUA \u015fi l-a \u00eenlocuit pe directorul general, Lars Fruergaard J\u00f8rgensen.<\/p>\n
\nLuna aceasta, grupul a anun\u0163at c\u0103 se a\u015fteapt\u0103 ca v\u00e2nz\u0103rile nete \u015fi profiturile din 2026 s\u0103 scad\u0103 cu p\u00e2n\u0103 la 13%, leg\u00e2nd aceast\u0103 evolu\u0163ie de reducerea pre\u0163urilor \u00een SUA, \u00een urma unui acord cu administra\u0163ia Donald Trump pentru sc\u0103derea costurilor medicamentelor pentru consumatori.<\/p>\n","protected":false},"excerpt":{"rendered":"
Ac\u0163iunile Novo Nordisk au sc\u0103zut cu 15% luni, cel mai recent medicament pentru sl\u0103bit al companiei daneze dezam\u0103gind \u00eentr-un studiu clinic, noteaz\u0103 FT. Investitorii au v\u00e2ndut ac\u0163iunile Novo Nordisk, listate la Copenhaga, dup\u0103 ce pierderea medie \u00een greutate ob\u0163inut\u0103 cu CagriSema, cea mai nou\u0103 injec\u0163ie s\u0103pt\u0103m\u00e2nal\u0103 a companiei, a fost sub nivelul ob\u0163inut de tirzepatid\u0103, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[14105,32260,15494,34037,29583],"class_list":["post-245356","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-dezamagire","tag-medicament","tag-novo-nordisk","tag-slabire","tag-studii-clinice"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/245356","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=245356"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/245356\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=245356"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=245356"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=245356"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}